Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
6
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
fda
eli lilly
abbvie
alzheimer's disease
boehringer ingelheim
cancer immunotherapy
merck
moderna
nivolumab
pfizer
startups
What
week
6
×
bio
roundup
companies
life
science
debut
drug
ipo
moves
rolls
sciences
therapeutics
acquisitions
alzheimer’s
american
annual
arena’s
ash
assessed
attention
big
biggest
biotech
biotechs
black
blood
bounty
build
buy
ceo
cig
club
comeback
communities
company’s
conference
continue
continued
corner
Language
unset
Current search:
week
×
national
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M